GKOS

Glaukos Corporation

113.33 USD
-0.15 (-0.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Glaukos Corporation stock is up 2.13% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 88.89% of the previous 9 June’s closed higher than May. In the last 3 Unusual Options Trades, there were 2 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 May 18:56 17 May, 2024 105.00 CALL 1000 75
16 May 15:37 17 May, 2024 105.00 CALL 1000 1036
30 May 17:31 18 Oct, 2024 115.00 PUT 22 0

About Glaukos Corporation

Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally.

  • Stifel
    Wed Jun 5, 08:45
    buy
    confirm
  • Wells Fargo
    Mon Jun 3, 14:33
    buy
    confirm
  • Citigroup
    Wed May 22, 13:24
    buy
    confirm